Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May;42(5):233-234.
doi: 10.1055/s-0040-1712941. Epub 2020 May 29.

Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article

Affiliations
Editorial

Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article

Luciano de Melo Pompei et al. Rev Bras Ginecol Obstet. 2020 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests to declare.

Comment on

References

    1. Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence Lancet 2019394(10204):1159–1168. - PMC - PubMed
    1. International Menopause Society. Comment on: Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence [Internet] 2019. [cited 2020 Mar 22]. Available from: https://www.imsociety.org/manage/images/pdf/5054afeb9b1bc763032333443f1c...
    1. Associação Brasileira de Climatério. Comentário da International Menopause Society sobre o artigo: Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence [Internet] 2019. [cited 2020 Mar 22]. Available from: http://sobrac.org.br/media/files/publicacoes/00002172_comentario_da_inte...
    1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 1997350(9084):1047–1059.. Doi: 10.1016/S0140-6736(97)08233-0 - PubMed
    1. Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 2003362(9382):419–427.. Doi: 10.1016/s0140-6736(03)14065-2 - PubMed

LinkOut - more resources